Letter: Helicobacter pylori -related non-alcoholic fatty liver disease with concomitant metabolic syndrome as risk factor for colorectal neoplasia

Abstract

Linked ContentThis article is linked to Ahn et al papers. To view these articles visit https://doi.org/10.1111/apt.13866 and https://doi.org/10.1111/apt.13911.

Letter: Helicobacter pylori and metabolic syndrome‐related von Willebrand factor and plasminogen activator inhibitor‐1 activity levels for outcome prediction of advanced chronic liver disease: Authors' reply

“…Letter: Helicobacter pylori and metabolic syndrome-related von Willebrand factor and plasminogen activator inhibitor-1 activity levels for outcome prediction of advanced chronic liver disease: Authors' reply Editors, We thank Dr. Kountouras et al for their interest in our work. 1,2 As outlined in our recent study 2 as well as previous work from our group, 3 there is little clinical evidence suggesting that levels of coagulation proteins (neither VWF nor the factor VIII/protein C ratio) per se represent disease-driving mechanisms in chronic liver disease. Rather, these factors appear to reflect the natural course of disease as their levels are strongly correlated with liver disease severity.…”